2005 News in Review: Important Changes for the Pharmaceutical - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/314799

2005 News in Review: Important Changes for the Pharmaceutical

Description:

This report casts a look back at 2005 and reviews key events and issues in the news that have had a major impact on the pharmaceutical industry or will help shape the industry in the years to come. The report covers ten important news stories:

- The Vioxx withdrawal.
- The Tysabri withdrawal.
- The approval of BiDil for African-Americans.
- Medicare Part D.
- The drug reimportation debate.
- Controversy about political involvement in the drug approval process.
- Concerns about a flu pandemic.
- EU Pharmaceutical Review.
- Reference pricing for statins in Germany.
- Increased consolidation in Japan.

Contents:

A Year of Change
Vioxx Withdrawal Prompts FDA Reform and Legal Battles
Biogen Idec and Elan Withdraw Tysabri
FDA Approves BiDil for African-American Patients
Medicare Part D: Final Regulations Released and Enrollment Begins
Debate Continues on Drug Reimportation Questions Arise Over
Political Involvement in Drug Approval Decisions
Concerns About a Flu Pandemic Increase
EU Pharmaceutical Review Is Incorporated in EU Member States
Reference Pricing for Statins Begins in Germany
Merger Activity in Japan Increases
Figure 1. Quarterly Sales of Celebrex and Bextra, 2004-2005
Figure 2. Yearly Prescription Drug Costs: Medicare Part D Compared with No Prescription Coverage
Table 1. Currently Marketed Flu Vaccines and Projected U.S. Supply for the 2005-2006 Influenza Season
Table 2. Select Mergers Between Japanese Companies, 2005

Companies Mentioned

Companies mentioned in this report include: - Biogen Idec - Elan - Merck - Pfizer - GlaxoSmithKline - Tanabe - Antisense Therapeutics - NitroMed - Medco Research/King Pharmaceuticals R&D - AstraZeneca - Barr Pharmaceuticals - Sandoz - Endo Labs - Forest Laboratories - Roche - Alnylam Pharmaceuticals - MedImmune - Yamanouchi/Fujisawa - Astellas - Takeda - Sankyo Pharmaceuticals/Daiichi Pharmaceuticals - Daiichi-Sankyo - Sumitomo Pharmaceuticals/Dainippon Pharmaceuticals - Dainippon Sumitomo - Novartis

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/314799

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 26/11/2009 03:59:45

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
2005 News in Review: Important Changes for the Pharmaceutical
Web Address:
http://www.researchandmarkets.com/reports/314799
Office Code:
OC8HJNMPMSTQQ

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Single User		€680.00

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 26/11/2009 03:59:45

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)